A single center, 2-period, single-sequence study evaluating effect of steady-state esomeprazole on the single-dose ceritinib PK in healthy subjects

Trial Profile

A single center, 2-period, single-sequence study evaluating effect of steady-state esomeprazole on the single-dose ceritinib PK in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Ceritinib (Primary) ; Esomeprazole
  • Indications Gastrointestinal cancer; Haematological malignancies; Non-small cell lung cancer; Solid tumours; Thyroid cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Jul 2017 New trial record
    • 01 Jun 2017 Results published in the Cancer Chemotherapy and Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top